title: Do molecular diagnostics add to clinical characteristics in selecting patients for gefitinib treatment?
authors.affiliation: Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
authors.forename: Yelena Y
authors.initials: YY
authors.lastname: Janjigian
authors.forename: Vincent A
authors.initials: VA
authors.lastname: Miller